CHINA China to strengthen medicine price monitoring


China to strengthen medicine price monitoring


02:36, December 10, 2019


Staff members work at a hospital's pharmacy in Shanghai in April 2019. (Photo: Xinhua)

BEIJING (Xinhua) -- China's National Healthcare Security Administration has issued a guideline to strengthen regular supervision on medicine prices.

The administration will adopt measures including monitoring, warning, information disclosure and credit appraisal, aiming to establish and improve an effective price monitoring mechanism to better leverage the role of the government under market conditions.

The guideline notes that a unified regional and national-level procurement mechanism will be established to promote information and resource sharing.

The guideline also stipulates that the current drug pricing policy should be improved to ensure the supply and reasonable prices for drugs that are in short supply.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue